Suppr超能文献

INI1/hSNF5诱导细胞周期停滞并抑制细胞周期蛋白D1转录

Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

作者信息

Zhang Zhi-Kai, Davies Kelvin P, Allen Jeffrey, Zhu Liang, Pestell Richard G, Zagzag David, Kalpana Ganjam V

机构信息

Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Mol Cell Biol. 2002 Aug;22(16):5975-88. doi: 10.1128/MCB.22.16.5975-5988.2002.

Abstract

INI1/hSNF5 is a component of the ATP-dependent chromatin remodeling hSWI/SNF complex and a tumor suppressor gene of aggressive pediatric atypical teratoid and malignant rhabdoid tumors (AT/RT). To understand the molecular mechanisms underlying its tumor suppressor function, we studied the effect of reintroduction of INI1/hSNF5 into AT/RT-derived cell lines such as MON that carry biallelic deletions of the INI1/hSNF5 locus. We demonstrate that expression of INI1/hSNF5 causes G(0)-G(1) arrest and flat cell formation in these cells. In addition, INI1/hSNF5 repressed transcription of cyclin D1 gene in MON, in a histone deacetylase (HDAC)-dependent manner. Chromatin immunoprecipitation studies revealed that INI1/hSNF5 was directly recruited to the cyclin D1 promoter and that its binding correlated with recruitment of HDAC1 and deacetylation of histones at the promoter. Analysis of INI1/hSNF5 truncations indicated that cyclin D1 repression and flat cell formation are tightly correlated. Coexpression of cyclin D1 from a heterologous promoter in MON was sufficient to eliminate the INI1-mediated flat cell formation and cell cycle arrest. Furthermore, cyclin D1 was overexpressed in AT/RT tumors. Our data suggest that one of the mechanisms by which INI1/hSNF5 exerts its tumor suppressor function is by mediating the cell cycle arrest due to the direct recruitment of HDAC activity to the cyclin D1 promoter thereby causing its repression and G(0)-G(1) arrest. Repression of cyclin D1 gene expression may serve as a useful strategy to treat AT/RT.

摘要

INI1/hSNF5是ATP依赖的染色质重塑hSWI/SNF复合物的一个组成部分,也是侵袭性儿童非典型畸胎瘤和恶性横纹肌样瘤(AT/RT)的一个肿瘤抑制基因。为了了解其肿瘤抑制功能的分子机制,我们研究了将INI1/hSNF5重新导入携带INI1/hSNF5基因座双等位基因缺失的AT/RT来源细胞系(如MON)的效果。我们证明,INI1/hSNF5的表达导致这些细胞出现G(0)-G(1)期阻滞和平坦细胞形成。此外,INI1/hSNF5以组蛋白去乙酰化酶(HDAC)依赖的方式抑制MON中细胞周期蛋白D1基因的转录。染色质免疫沉淀研究表明,INI1/hSNF5被直接招募到细胞周期蛋白D1启动子,其结合与HDAC1的招募以及启动子处组蛋白的去乙酰化相关。对INI1/hSNF5截短体的分析表明,细胞周期蛋白D1的抑制和平坦细胞形成紧密相关。在MON中从异源启动子共表达细胞周期蛋白D1足以消除INI1介导的平坦细胞形成和细胞周期阻滞。此外,细胞周期蛋白D1在AT/RT肿瘤中过表达。我们的数据表明,INI1/hSNF5发挥其肿瘤抑制功能的机制之一是通过将HDAC活性直接招募到细胞周期蛋白D1启动子,从而导致其抑制和G(0)-G(1)期阻滞,进而介导细胞周期阻滞。抑制细胞周期蛋白D1基因表达可能是治疗AT/RT的一种有效策略。

相似文献

1
Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
Mol Cell Biol. 2002 Aug;22(16):5975-88. doi: 10.1128/MCB.22.16.5975-5988.2002.
2
Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Cancer Res. 2011 May 1;71(9):3225-35. doi: 10.1158/0008-5472.CAN-10-2167. Epub 2011 Apr 26.
4
Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
J Neurooncol. 2005 Jun;73(2):117-24. doi: 10.1007/s11060-004-4276-4.
5
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12129-34. doi: 10.1073/pnas.0505300102. Epub 2005 Aug 12.
6
Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.
Oncogene. 2006 Feb 2;25(5):722-34. doi: 10.1038/sj.onc.1209112.
7
P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
J Biol Chem. 2004 Jan 30;279(5):3807-16. doi: 10.1074/jbc.M309333200. Epub 2003 Nov 6.
8
The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
Cancer Res. 2004 May 15;64(10):3406-13. doi: 10.1158/0008-5472.CAN-03-3004.
9
Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
Cancer Res. 2010 Mar 1;70(5):1854-65. doi: 10.1158/0008-5472.CAN-09-1922. Epub 2010 Feb 23.

引用本文的文献

2
Molecular Biomarkers of Glioma.
Biomedicines. 2025 May 26;13(6):1298. doi: 10.3390/biomedicines13061298.
3
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.
Nat Rev Urol. 2025 Jan 29. doi: 10.1038/s41585-024-00993-6.
4
AURKA/PLK1/CDC25C Axis as a Novel Therapeutic Target in INI1-Deficient Epithelioid Sarcoma.
Cancer Sci. 2025 Apr;116(4):976-989. doi: 10.1111/cas.16438. Epub 2025 Jan 9.
8
Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors.
Cancer Med. 2023 Aug;12(15):16323-16336. doi: 10.1002/cam4.6255. Epub 2023 Jun 14.

本文引用的文献

1
DNA content measurement for DNA ploidy and cell cycle analysis.
Curr Protoc Cytom. 2001 May;Chapter 7:Unit 7.5. doi: 10.1002/0471142956.cy0705s00.
4
Specific protection against breast cancers by cyclin D1 ablation.
Nature. 2001 Jun 28;411(6841):1017-21. doi: 10.1038/35082500.
5
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.
Mol Cell Biol. 2001 May;21(10):3598-603. doi: 10.1128/MCB.21.10.3598-3603.2001.
8
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13796-800. doi: 10.1073/pnas.250492697.
9
The Pezcoller lecture: cancer cell cycles revisited.
Cancer Res. 2000 Jul 15;60(14):3689-95.
10
BRG-1 is required for RB-mediated cell cycle arrest.
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7748-53. doi: 10.1073/pnas.97.14.7748.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验